Almandoz, Jaime P. https://orcid.org/0000-0002-0462-0843
Lingvay, Ildiko https://orcid.org/0000-0001-7006-7401
Morales, Javier https://orcid.org/0000-0003-1005-0311
Campos, Carlos
Clinical trials referenced in this document:
Documents that mention this clinical trial
An overview of GLP-1 agonists and recent cardiovascular outcomes trials
https://doi.org/10.1136/postgradmedj-2019-137186
Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial
https://doi.org/10.1161/circulationaha.125.074545
Optimizing Therapeutic Outcomes With Oral Semaglutide: A Patient-Centered Approach
https://doi.org/10.2337/ds20-0016
Switching Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance
https://doi.org/10.2337/cd19-0100